Strategic Initiative
Slingshot members are tracking this corporate initiative:
PharmaMar (PHM.MC) Agrees to Licensing Agreement with Boryung Pharm for Aplidin in South Korea
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PHM.MC |
|
|
Boryung Pharm |
|
|
|
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Oct 04, 2016 Projected Implementation: Q4, 2016 Relevance Tracked Until: Q4, 2018
Related Projects
-
Don’t see a project related to the strategic initiative you care about?
Related Keywords
Aplidin, Cancer, Licensing Agreement
